Literature DB >> 28766181

Treatment of Amlodipine Intoxication with Intravenous Lipid Emulsion Therapy: A Case Report and Review of the Literature.

Funda Karbek Akarca1, Ece Akceylan2, Selahattin Kıyan2.   

Abstract

We report the case of a 25-year-old female presenting to the emergency department after committing suicide by ingesting 100 mg amlodipine. The patient was initially treated with intravenous fluids, calcium gluconate, catecholamines and glucagone without effect. The clinical condition of the patient improved quickly and dramatically on the 20th minute of intravenous lipid emulsion (ILE) therapy. Different treatment methods have been developed for calcium channel blocker intoxication over the last years. Among these, lipid emulsion therapy has risen over the last decade as a salvation in cases which do not respond to other treatments. However, given the paucity of data, there are conflicting recommendations about the indications, dose and timing of ILE in the literature. In the light of this case report, we review the literature and discuss whether ILE therapy can find itself a place among first-line therapy recommendations.

Entities:  

Keywords:  Amlodipine toxicity; Calcium channel blocker; Intravenous lipid emulsion; Lipid emulsion therapy

Mesh:

Substances:

Year:  2017        PMID: 28766181     DOI: 10.1007/s12012-017-9421-3

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  3 in total

1.  Amlodipine toxicity and lipid emulsion.

Authors:  Seong-Ho Ok; Ju-Tae Sohn
Journal:  Korean J Anesthesiol       Date:  2018-05-30

2.  Multi-organ dysfunction as a presentation of calcium channel blocker intoxication.

Authors:  Abdul-Fatawu Osman; Rohan Madhu Prasad; Shawn Marein; Corey O'Brien
Journal:  BMJ Case Rep       Date:  2022-01-17

3.  Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat.

Authors:  Audrey E Tinsman; Tara J Bellis
Journal:  Clin Case Rep       Date:  2021-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.